Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly

Br J Haematol. 2016 Jul;174(1):160-2. doi: 10.1111/bjh.13758. Epub 2015 Oct 28.
No abstract available

Keywords: myelofibrosis; ruxolitinib; splenomegaly.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nitriles
  • Organ Size
  • Primary Myelofibrosis / drug therapy*
  • Primary Myelofibrosis / pathology
  • Pyrazoles / agonists*
  • Pyrimidines
  • Spleen
  • Splenomegaly
  • Treatment Outcome

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib